New Partnership with DrFirst ePrescribe Gives Members One Click Access to the Connecticut Prescription Monitoring and Reporting System

Easy access to more thorough prescribing history boosts members’ clinical decision-making and improves patient health outcomes

The Connecticut State Medical Society (CSMS), representing more than 6,000 physicians in Connecticut, has selected DrFirst, a leading provider of e-prescribing and patient medication management solutions, as the vendor of choice for its robust e-prescribing tool, iPrescribe, for its members.

iPrescribe, for iOS or Android smartphones, will provide Connecticut physicians with seamless and automatic access to prescription data from the Connecticut Prescription Monitoring and Reporting System (CPMRS) with one click for more informed decision making at the point of care. With trustworthy, patient-level prescribing history, iPrescribe gives physicians insight into a patient’s risk for abuse or addiction to opioids or other controlled substances. Additionally, iPrescribe helps clinicians improve patient safety and adherence with its accurate medication history and clinical support from directly within the prescribing workflow.

“The partnership between CSMS and DrFirst will give our physicians access to reliable, real-time access to important medication history contained in the CPMRS to assure that patients receive the medication most appropriate to their medical needs,” said Matthew Katz, CSMS EVP/CEO.

“Prior to using iPrescribe, a physician would have to log into the CPMRS site separately, do another set of data entry, check medication history, then go back into his or her EHR to write the prescription and, finally, send it to the pharmacy electronically. iPrescribe brings a new level efficiency to the prescribing process by automatically connecting to and retrieving data from the CPMRS,” said Steven Thornquist, MD, CSMS President. “Once a prescription is written, that information is added to the EMR and in the CPMRS.”

The partnership of CSMS and DrFirst gives CSMS members free use of iPrescribe for one year with a substantial discount off the retail price in subsequent years.  Connecticut physicians can enroll in iPrescribe at

“iPrescribe will simplify the prescribing process for Connecticut clinicians through access to deeper, dependable data,” said G. Cameron Deemer, president of DrFirst. “We are very pleased to have entered into this close partnership with the Connecticut State Medical Society to give its physicians members better tools that will help them improve the health and safety of their patients.”

“We’re pleased that DrFirst has been able to make this integration,” said Consumer Protection Commissioner Michelle H. Seagull, “They will join a pharmacy and two hospitals as institutions who have completed this process. DrFirst is a great tool that can support physicians with both electronic prescribing, and compliance with PDMP laws and regulations. We value the partnership of DrFirst and the Connecticut Medical Society, and look forward to working together in the future.”

About DrFirst

DrFirst, the nation’s leading provider of e-prescribing and medication management solutions, enables stakeholders across the healthcare industry to intelligently use comprehensive real-time data and connectivity to increase their patient safety ratings, efficiency, and profitability. Today, more than 170,000 healthcare professionals and more than 60% of electronic health record vendors, depend on DrFirst’s innovative software solutions to improve clinical workflows, expedite secure collaboration across a patient’s care team, and drive better health outcomes. The company’s integrated technologies include its award-winning electronic prescribing platform, the most comprehensive medication history available, clinically specialized secure messaging, as well as patient medication adherence monitoring and benefits checking. In addition, DrFirst was the first to offer e-prescribing for controlled substances (EPCS), which is considered the industry standard for providers nationwide. For more information, please visit or connect with us @DrFirst